Provided by Tiger Trade Technology Pte. Ltd.

CHINARES PHARMA

4.470
-0.100-2.19%
Volume:12.85M
Turnover:57.71M
Market Cap:28.09B
PE:5.96
High:4.600
Open:4.600
Low:4.470
Close:4.570
52wk High:6.336
52wk Low:4.211
Shares:6.28B
HK Float Shares:6.28B
Volume Ratio:1.20
T/O Rate:0.20%
Dividend:0.22
Dividend Rate:4.87%
EPS(LYR):0.750
ROE:8.32%
ROA:2.64%
PB:0.46
PE(LYR):5.96
PS:0.09

Loading ...

BRIEF-China Resources Pharmaceutical Says QTRLY Net Profit For CR Jiangzhong RMB312.0 MLN

Reuters
·
Apr 24

CHINARES PHARMA Subsidiary Tasly Pharmaceutical Delivers 5.35% Revenue and 9.78% Profit Growth in Q1 2026

Bulletin Express
·
Apr 24

CR Pharma’s Dong-E-E-Jiao Posts 7.1% Profit Growth in Q1 2026, Cash Reserves Surge

Bulletin Express
·
Apr 24

CR Double-Crane Q1 2026 Revenue Down 8.84%, Net Profit Declines 4.08%; Majority-Owned by CR Pharma

Bulletin Express
·
Apr 24

CR Double-Crane Q1 net profit falls to RMB 501.38 million

Reuters
·
Apr 24

Dong-E-E-Jiao Q1 net profit rises to RMB 454.77 million

Reuters
·
Apr 24

China Resources Pharma's Dong-E-E-Jiao Reports Q1 Net Profit of 455 Million Yuan, Up 7.12%

Stock News
·
Apr 24

China Resources Pharmaceutical - China Resources Double-Crane Pharmaceutical Q1 Revenue RMB2.81 Bln

THOMSON REUTERS
·
Apr 24

CR Pharma Completes RMB1.50 Billion First-Tranche Issuance of 2026 Corporate Bonds at 1.65% Coupon

Bulletin Express
·
Apr 16

China Resources Pharma Subsidiary Concludes RMB 1.5 Billion Corporate Bond Issuance

Stock News
·
Apr 16

China Resources Pharma unit issues RMB 1.5 billion three-year bonds at 1.65%

Reuters
·
Apr 16

BrainAurora appoints Yang Fan, Wang Jingbo as non-executive directors

Reuters
·
Apr 15

DIARY-China corporate earnings week ahead

Reuters
·
Apr 03

CHINARES PHARMA Keeps Share Base Unchanged at 6.28 Billion in March 2026, Confirms Public Float Compliance

Bulletin Express
·
Apr 01

A Look At China Resources Pharmaceutical Group (SEHK:3320) Valuation After 2025 Results And Higher Dividend Proposal

Simply Wall St.
·
Mar 30

CHINARES PHARMA Subsidiary CR Pharmaceutical Commercial Completes RMB1.80 Billion First-Tranche 2026 Bond Issue at 1.70% Coupon

Bulletin Express
·
Mar 27

CHINARES PHARMA Subsidiary Successfully Issues 1.8 Billion Yuan Corporate Bonds

Stock News
·
Mar 27

China Resources Pharmaceutical affiliate CR Pharmaceutical Commercial issues 2026 corporate bonds; RMB1.8 billion tranche sets 1.70% coupon

Reuters
·
Mar 27

CLSA Maintains Outperform Rating on China Resources Pharmaceutical, Raises Target Price to HK$7.2

Stock News
·
Mar 27

CMSC International Raises CHINARES PHARMA (03320) Target Price to HK$6.3, Keeps "Add" Rating

Stock News
·
Mar 27